All Stories

  1. Systematic research to overcome newly emerged multidrug resistant bacteria

    Article • Microbiology and Immunology, February 2020, Wiley

    Dr Yoshichika Arakawa

  2. Potential effect of selective pressure with different β‐lactam molecules on the emergence of reduced susceptibility to β‐lactams in group B Streptococci

    Article • Microbiology and Immunology, February 2019, Wiley

    Dr Yoshichika Arakawa

  3. Isolation of group B Streptococcus with reduced β-lactam susceptibility from pregnant women

    Article • Emerging Microbes & Infections, January 2019, Taylor & Francis

    Dr Yoshichika Arakawa

  4. High rate of slowly-killed-by-ampicillin phenotype among group B streptococci with reduced penicillin susceptibility: Table 1

    Article • Journal of Antimicrobial Chemotherapy, December 2016, Oxford University Press (OUP)

    Dr Yoshichika Arakawa

  5. High prevalence of fosfomycin resistance gene fosA3 in bla CTX-M-harbouring Escherichia coli from urine in a Chinese tertiary hospital during 2010–2014

    Article • Epidemiology and Infection, December 2016, Cambridge University Press

    Dr Yoshichika Arakawa

  6. Reduction in chlorhexidine efficacy against multi-drug resistant Acinetobacter baumannii international clone II

    Article • Journal of Hospital Infection, December 2016, Elsevier

    Dr Yoshichika Arakawa

  7. In vitro reduction of antibacterial activity of tigecycline against multidrug-resistant Acinetobacter baumannii with host stress hormone norepinephrine

    Article • International Journal of Antimicrobial Agents, December 2016, Elsevier

    Dr Yoshichika Arakawa

  8. Effectual detection of group B streptococci with reduced penicillin susceptibility (PRGBS) by commercially available methicillin-resistant-Staphylococcus aureus (MRSA)-selective agar

    Article • Diagnostic Microbiology and Infectious Disease, July 2016, Elsevier

    Dr Yoshichika Arakawa

  9. Aminoglycoside Resistance

    Article • Infectious Disease Clinics of North America, June 2016, Elsevier

    Dr Yoshichika Arakawa

  10. Structural Insights into Recognition of Hydrolyzed Carbapenems and Inhibitors by Subclass B3 Metallo-β-Lactamase SMB-1

    Article • Antimicrobial Agents and Chemotherapy, May 2016, ASM Journals

    Dr Yoshichika Arakawa

  11. A Novel IgM-capture enzyme-linked immunosorbent assay using recombinant Vag8 fusion protein for the accurate and early diagnosis ofBordetella pertussisinfection

    Article • Microbiology and Immunology, May 2016, Wiley

    Dr Yoshichika Arakawa

  12. A Highly Macrolide-Resistant Campylobacter jejuni Strain with Rare A2074T Mutations in 23S rRNA Genes

    Article • Antimicrobial Agents and Chemotherapy, January 2016, ASM Journals

    Dr Yoshichika Arakawa

  13. Long-Term Colonization byblaCTX-M-Harboring Escherichia coli in Healthy Japanese People Engaged in Food Handling

    Article • Applied and Environmental Microbiology, January 2016, ASM Journals

    Dr Yoshichika Arakawa

  14. Third-generation cephalosporin-resistant non-typhoidal Salmonella isolated from human feces in Japan

    Article • Japanese Journal of Infectious Diseases, January 2016, Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis

    Dr Yoshichika Arakawa

  15. Characterization of Piperacillin/Tazobactam-Resistant Klebsiella oxytoca Recovered from a Nosocomial Outbreak

    Article • PLoS ONE, November 2015, PLOS

    Dr Yoshichika Arakawa

  16. Development of a novel chromogenic method, Penta-well test, for rapid prediction of β-lactamase classes produced in clinical Enterobacteriaceae isolates

    Article • Diagnostic Microbiology and Infectious Disease, September 2015, Elsevier

    Dr Yoshichika Arakawa

  17. Ceftibuten-containing agar plate for detecting group B streptococci with reduced penicillin susceptibility (PRGBS)

    Article • Diagnostic Microbiology and Infectious Disease, August 2015, Elsevier

    Dr Yoshichika Arakawa

  18. High isolation rate of MDR group B streptococci with reduced penicillin susceptibility in Japan

    Article • Journal of Antimicrobial Chemotherapy, July 2015, Oxford University Press (OUP)

    Dr Yoshichika Arakawa

  19. Successful Containment of Multidrug-Resistant Acinetobacter baumannii ST215 Outbreak in Japanese University Hospital

    Article • American Journal of Infection Control, June 2015, Elsevier

    Dr Yoshichika Arakawa

  20. Genetic Profiles of Fluoroquinolone-Nonsusceptible Klebsiella pneumoniae Among Cephalosporin-Resistant K. pneumoniae

    Article • Microbial Drug Resistance, April 2015, Mary Ann Liebert Inc

    Dr Yoshichika Arakawa

  21. New plasmid-mediated aminoglycoside 6′-N-acetyltransferase, AAC(6′)-Ian, and ESBL, TLA-3, from aSerratia marcescensclinical isolate

    Article • Journal of Antimicrobial Chemotherapy, January 2015, Oxford University Press (OUP)

    Dr Yoshichika Arakawa

  22. Molecular Epidemiological Characteristics of Klebsiella pneumoniae Associated with Bacteremia among Patients with Pneumonia

    Article • Journal of Clinical Microbiology, January 2015, ASM Journals

    Dr Yoshichika Arakawa

  23. Contribution of QnrA, a Plasmid-Mediated Quinolone Resistance Peptide, to Survival of Escherichia coli Exposed to a Lethal Ciprofloxacin Concentration

    Article • Japanese Journal of Infectious Diseases, January 2015, Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis

    Dr Yoshichika Arakawa

  24. Comparative Analysis of Penicillin-Susceptible and Non-Susceptible Isolates of Group B Streptococci by Multilocus Sequence Typing

    Article • Japanese Journal of Infectious Diseases, January 2015, Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis

    Dr Yoshichika Arakawa

  25. Crystal Structure of IMP-2 Metallo-β-lactamase from Acinetobacter spp.

    Article • Biological and Pharmaceutical Bulletin, January 2015, Pharmaceutical Society of Japan

    Dr Yoshichika Arakawa

  26. Molecular Epidemiological Characterization of Uropathogenic Escherichia coli from an Outpatient Urology Clinic in Rural Japan

    Article • Journal of Clinical Microbiology, November 2014, ASM Journals

    Dr Yoshichika Arakawa

  27. Roles of Ala-149 in the catalytic activity of diadenosine tetraphosphate phosphorylase fromMycobacterium tuberculosisH37Rv

    Article • Bioscience Biotechnology and Biochemistry, October 2014, Taylor & Francis

    Dr Yoshichika Arakawa

  28. Loop-mediated isothermal amplification assay for 16S rRNA methylase genes in Gram-negative bacteria

    Article • Journal of Infection and Chemotherapy, October 2014, Elsevier

    Dr Yoshichika Arakawa

  29. Invasive Infection Caused by Carbapenem-Resistant Acinetobacter soli , Japan

    Article • Emerging Infectious Diseases, September 2014, Centers for Disease Control and Prevention (CDC)

    Dr Yoshichika Arakawa

  30. Practical Agar-Based Disk Potentiation Test for Detection of Fosfomycin-Nonsusceptible Escherichia coli Clinical Isolates Producing GlutathioneS-Transferases

    Article • Journal of Clinical Microbiology, June 2014, ASM Journals

    Dr Yoshichika Arakawa

  31. Penicillin-Susceptible Group B Streptococcal Clinical Isolates with Reduced Cephalosporin Susceptibility

    Article • Journal of Clinical Microbiology, June 2014, ASM Journals

    Dr Yoshichika Arakawa

  32. New PCR-Based Open Reading Frame Typing Method for Easy, Rapid, and Reliable Identification of Acinetobacter baumannii International Epidemic Clones without Performing Multilocus Sequence Typing

    Article • Journal of Clinical Microbiology, June 2014, ASM Journals

    Dr Yoshichika Arakawa

  33. Distribution of carbapenem resistance determinants among epidemic and non-epidemic types of Acinetobacter species in Japan

    Article • Journal of Medical Microbiology, June 2014, Society for General Microbiology

    Dr Masato Suzuki, Dr Yoshichika Arakawa

  34. Novel Integron-Mediated Fosfomycin Resistance GenefosK

    Article • Antimicrobial Agents and Chemotherapy, May 2014, ASM Journals

    Dr Yoshichika Arakawa

  35. Molecular Epidemiology of Extended-Spectrum β-Lactamases and Escherichia coli Isolated from Retail Foods Including Chicken Meat in Japan

    Article • Foodborne Pathogens and Disease, February 2014, Mary Ann Liebert Inc

    Dr Yoshichika Arakawa

  36. First Detection of Fosfomycin Resistance Gene fosA3 in CTX-M-Producing Escherichia coli Isolates from Healthy Individuals in Japan

    Article • Microbial Drug Resistance, December 2013, Mary Ann Liebert Inc

    Dr Yoshichika Arakawa

  37. Rapid discrimination of Acinetobacter baumannii international clone II lineage by pyrosequencing SNP analyses of bla OXA-51-like genes

    Article • Journal of Microbiological Methods, August 2013, Elsevier

    Dr Masato Suzuki, Dr Yoshichika Arakawa

  38. Influenza A whole virion vaccine induces a rapid reduction of peripheral blood leukocytes via interferon-α-dependent apoptosis

    Article • Vaccine, April 2013, Elsevier

    Yoshinobu Horiuchi, Dr Masato Tashiro, Dr Yoshichika Arakawa

  39. Comparison of Test Methods for Detecting Metallo-β-Lactamase-Producing Gram-Negative Bacteria

    Article • Japanese Journal of Infectious Diseases, January 2013, Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis

    Dr Yoshichika Arakawa

  40. Rapid and Reliable Loop-Mediated Isothermal Amplification Method for Detecting Streptococcus agalactiae

    Article • Japanese Journal of Infectious Diseases, January 2013, Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis

    Dr Yoshichika Arakawa

  41. Screening for Group B Streptococci with Reduced Penicillin Susceptibility in Clinical Isolates Obtained between 1977 and 2005

    Article • Japanese Journal of Infectious Diseases, January 2013, Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis

    Dr Yoshichika Arakawa

  42. First Report of OXA-48 Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli in Japan from a Patient Returned from Southeast Asia

    Article • Japanese Journal of Infectious Diseases, January 2013, Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis

    Dr Yoshichika Arakawa

  43. Active Screening of Group B Streptococci with Reduced Penicillin Susceptibility and Altered Serotype Distribution Isolated from Pregnant Women in Kobe, Japan

    Article • Japanese Journal of Infectious Diseases, January 2013, Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis

    Dr Yoshichika Arakawa

  44. Exogenously acquired 16S rRNA methyltransferases found in aminoglycoside-resistant pathogenic Gram-negative bacteria: An update

    Article • Drug Resistance Updates, June 2012, Elsevier

    Dr Yoshichika Arakawa

  45. Prevalence and Genetic Characterization of Pertactin-Deficient Bordetella pertussis in Japan

    Article • PLoS ONE, February 2012, PLOS

    Dr Yoshichika Arakawa

  46. Ultra-late Onset Group B Streptococcal Disease ―A Report of Two Cases―

    Article • Kansenshogaku zasshi, January 2012, The Japanese Association for Infectious Diseases

    Dr Yoshichika Arakawa

  47. Complete Sequencing of the blaNDM-1-Positive IncA/C Plasmid from Escherichia coli ST38 Isolate Suggests a Possible Origin from Plant Pathogens

    Article • PLoS ONE, September 2011, PLOS

    Dr Yoshichika Arakawa

  48. A Demetallation Method for IMP-1 Metallo-β-Lactamase with Restored Enzymatic Activity Upon Addition of Metal Ion(s)

    Article • ChemBioChem, July 2011, Wiley

    Dr Yoshichika Arakawa

  49. Structural Insights into the Novel Diadenosine 5′,5‴-P1,P4-Tetraphosphate Phosphorylase from Mycobacterium tuberculosis H37Rv

    Article • Journal of Molecular Biology, July 2011, Elsevier

    Dr Yoshichika Arakawa

  50. Biochemical and pathophysiological characterization of Helicobacter pylori asparaginase

    Article • Microbiology and Immunology, May 2011, Wiley

    Dr Yoshichika Arakawa

  51. Practical Disk-Based Method for Detection of Escherichia coli Clinical Isolates Producing the Fluoroquinolone-Modifying Enzyme AAC(6′)-Ib-cr: Fig. 1.

    Article • Journal of Clinical Microbiology, April 2011, ASM Journals

    Dr Yoshichika Arakawa

  52. Differential Expression of Type III Effector BteA Protein Due to IS481 Insertion in Bordetella pertussis

    Article • PLoS ONE, March 2011, PLOS

    Dr Yoshichika Arakawa

  53. Metal preference of Zn(ii) and Co(ii) for the dinuclear metal binding site of IMP-1 metallo-β-lactamase and spectroscopic properties of Co(ii)-substituted IMP-1 with mercaptoacetic acid

    Article • MedChemComm, January 2011, Royal Society of Chemistry

    Dr Yoshichika Arakawa

  54. RmtC introduces G1405 methylation in 16S rRNA and confers high-level aminoglycoside resistance on Gram-positive microorganisms

    Article • FEMS Microbiology Letters, August 2010, Oxford University Press (OUP)

    Dr Yoshichika Arakawa

  55. Profile of Expression of Helicobacter pyloriγ-Glutamyltranspeptidase

    Article • Helicobacter, June 2010, Wiley

    Dr Yoshichika Arakawa

  56. Characterization of Quasispecies of Pandemic 2009 Influenza A Virus (A/H1N1/2009) by De Novo Sequencing Using a Next-Generation DNA Sequencer

    Article • PLoS ONE, April 2010, PLOS

    Dr Yoshichika Arakawa

  57. Genetic verification of Bordetella pertussis seed strains used for production of Japanese acellular pertussis vaccines

    Article • Biologicals, March 2010, Elsevier

    Dr Yoshichika Arakawa

  58. Practical Disk Diffusion Test for Detecting Group B Streptococcus with Reduced Penicillin Susceptibility

    Article • Journal of Clinical Microbiology, February 2010, ASM Journals

    Dr Yoshichika Arakawa

  59. Crystallization and preliminary X-ray analysis of the diadenosine 5′,5′′′-P1,P4-tetraphosphate phosphorylase fromMycobacterium tuberculosisH37Rv

    Article • Acta Crystallographica Section F Structural Biology and Crystallization Communications, February 2010, International Union of Crystallography

    Dr Yoshichika Arakawa

  60. The Nosocomial Transmission of Helicobacter cinaedi Infections in Immunocompromised Patients

    Article • Internal Medicine, January 2010, Japanese Society of Internal Medicine

    Dr Yoshichika Arakawa

  61. An Outbreak of Histoplasmosis among Healthy Young Japanese Women after Traveling to Southeast Asia

    Article • Internal Medicine, January 2010, Japanese Society of Internal Medicine

    Dr Yoshichika Arakawa

  62. Purification and molecular characterization of a novel diadenosine 5′,5′′′-P1,P4-tetraphosphate phosphorylase from Mycobacterium tuberculosis H37Rv

    Article • Protein Expression and Purification, January 2010, Elsevier

    Dr Yoshichika Arakawa

  63. A novel insertion sequence, IS1642, ofMycobacterium avium, which forms long direct repeats of variable length

    Article • FEMS Microbiology Letters, February 2009, Oxford University Press (OUP)

    Dr Yoshichika Arakawa

  64. Difference of genotypic and phenotypic characteristics and pathogenicity potential of Photobacterium damselae subsp. damselae between clinical and environmental isolates from Japan

    Article • Microbial Pathogenesis, August 2008, Elsevier

    Dr Yoshichika Arakawa

  65. Antigenic variation in Bordetella pertussis isolates recovered from adults and children in Japan

    Article • Vaccine, March 2008, Elsevier

    Dr Yoshichika Arakawa

  66. Crystallographic Investigation of the Inhibition Mode of a VIM-2 Metallo-β-lactamase from Pseudomonas aeruginosa by a Mercaptocarboxylate Inhibitor

    Article • Journal of Medicinal Chemistry, December 2007, American Chemical Society (ACS)

    Dr Yoshichika Arakawa

  67. Highly sensitive histamine-sensitization test for residual activity of pertussis toxin in acellular pertussis vaccine

    Article • Biologicals, October 2007, Elsevier

    Dr Yoshichika Arakawa

  68. Quantification of two variant strains contained in freeze-dried Japanese BCG vaccine preparation by real-time PCR

    Article • Biologicals, April 2007, Elsevier

    Dr Yoshichika Arakawa

  69. 16S rRNA Methylase–producing, Gram-Negative Pathogens, Japan

    Article • Emerging Infectious Diseases, April 2007, Centers for Disease Control and Prevention (CDC)

    Dr Yoshichika Arakawa

  70. Metabolism of glutamine and glutathione via γ-glutamyltranspeptidase and glutamate transport in Helicobacter pylori: possible significance in the pathophysiology of the organism

    Article • Molecular Microbiology, March 2007, Wiley

    Dr Yoshichika Arakawa

  71. Development of safer pertussis DNA vaccine expressing non-toxic C180 polypeptide of pertussis toxin S1 subunit

    Article • Vaccine, January 2007, Elsevier

    Dr Yoshichika Arakawa

  72. Toxoid flocculation assay by laser light-scattering

    Article • Journal of Immunological Methods, January 2007, Elsevier

    Dr Yoshichika Arakawa

  73. Outbreak of CTX-M-3-type extended-spectrum β-lactamase-producing Enterobacter cloacae in a pediatric ward

    Article • Journal of Infection and Chemotherapy, January 2007, Elsevier

    Dr Yoshichika Arakawa

  74. Dissemination of 16S rRNA methylase-mediated highly amikacin-resistant isolates of Klebsiella pneumoniae and Acinetobacter baumannii in Korea

    Article • Diagnostic Microbiology and Infectious Disease, November 2006, Elsevier

    Dr Yoshichika Arakawa

  75. Probing, Inhibition, and Crystallographic Characterization of Metallo-β-lactamase (IMP-1) with Fluorescent Agents Containing Dansyl and Thiol Groups

    Article • ChemMedChem, September 2006, Wiley

    Dr Yoshichika Arakawa

  76. Prevalence of the speA2 and speA3 alleles in Streptococcus pyogenes isolated from TSLS patients in Japan

    Article • FEMS Microbiology Letters, January 2006, Oxford University Press (OUP)

    Dr Yoshichika Arakawa

  77. Irreversible Inhibition of Metallo-β-lactamase (IMP-1) by 3-(3-Mercaptopropionylsulfanyl)propionic Acid Pentafluorophenyl Ester

    Article • Angewandte Chemie, June 2005, Wiley

    Dr Yoshichika Arakawa

  78. Irreversible Inhibition of Metallo-β-lactamase (IMP-1) by 3-(3-Mercaptopropionylsulfanyl)propionic Acid Pentafluorophenyl Ester

    Article • Angewandte Chemie, June 2005, Wiley

    Dr Yoshichika Arakawa

  79. Global Spread of Multiple Aminoglycoside Resistance Genes

    Article • Emerging Infectious Diseases, June 2005, Centers for Disease Control and Prevention (CDC)

    Dr Yoshichika Arakawa

  80. Severe Acute Tonsillitis Caused By Rothia Dentocariosa in a Healthy Child

    Article • The Pediatric Infectious Disease Journal, May 2005, Wolters Kluwer Health

    Dr Yoshichika Arakawa

  81. Growth Competition of Macrolide-Resistant and -SusceptibleHelicobacter pyloriStrains

    Article • Microbiology and Immunology, December 2004, Wiley

    Dr Yoshichika Arakawa

  82. Where has vancomycin-heterogeneously resistant Staphylococcus aureus gone?

    Article • The Lancet, April 2004, Elsevier

    Dr Yoshichika Arakawa

  83. Augmenting Effect of Antibiotics on Endotoxin Activity May Cause a Safety Problem

    Article • Microbiology and Immunology, February 2004, Wiley

    Dr Yoshichika Arakawa

  84. Escherichia coliProducing CTX-M-2 β-Lactamase in Cattle, Japan

    Article • Emerging Infectious Diseases, January 2004, Centers for Disease Control and Prevention (CDC)

    Dr Yoshichika Arakawa

  85. Comparative Study of the Inhibition of Metallo-β-Lactamases (IMP-1 and VIM-2) by Thiol Compounds That Contain a Hydrophobic Group

    Article • Biological and Pharmaceutical Bulletin, January 2004, Pharmaceutical Society of Japan

    Dr Yoshichika Arakawa

  86. Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa

    Article • The Lancet, December 2003, Elsevier

    Dr Yoshichika Arakawa

  87. DNA vaccine encoding pertussis toxin S1 subunit induces protection against Bordetella pertussis in mice

    Article • Vaccine, November 2003, Elsevier

    Dr Yoshichika Arakawa

  88. A novel apoptosis-inducing protein from Helicobacter pylori

    Article • Molecular Microbiology, January 2003, Wiley

    Dr Yoshichika Arakawa

  89. Detection of a metallo-β-lactamase (IMP-1) by fluorescent probes having dansyl and thiol groups

    Article • Organic & Biomolecular Chemistry, January 2003, Royal Society of Chemistry

    Dr Yoshichika Arakawa

  90. Dependence of Hydrolysis of β-Lactams with a Zinc(II)-β-Lactamase Produced from Serratia marcescens (IMP-1) on pH and Concentration of Zinc(II) Ion: Dissociation of Zn(II) from IMP-1 in Acidic Medium

    Article • Biological and Pharmaceutical Bulletin, January 2003, Pharmaceutical Society of Japan

    Dr Yoshichika Arakawa

  91. CHARACTERIZATION OF KLEBSIELLA PNEUMONIAE AND ESCHERICHIA COLI STRAINS THAT PRODUCE CTX-M-2-TYPE BROAD SPECTRUM BETA-LACTAMASE ISOLATED FROM A CHILD WITH LEUKEMIA

    Article • The Pediatric Infectious Disease Journal, March 2002, Wolters Kluwer Health

    Dr Yoshichika Arakawa

  92. Characteristics of Macrolide-ResistantMycoplasma pneumoniaeStrains Isolated from Patients and Induced with ErythromycinIn Vitro

    Article • Microbiology and Immunology, August 2001, Wiley

    Dr Yoshichika Arakawa

  93. Direct screening of the IMP-1 metallo-beta-lactamase gene (blaIMP) from urine samples by polymerase chain reaction

    Article • International Journal of Urology, March 2001, Wiley

    Dr Yoshichika Arakawa

  94. Synthesis of variously oxidized abietane diterpenes and their antibacterial activities against MRSA and VRE

    Article • Bioorganic & Medicinal Chemistry, February 2001, Elsevier

    Dr Yoshichika Arakawa

  95. Trends in Antimicrobial-Drug Resistance in Japan

    Article • December 2000, Centers for Disease Control and Prevention (CDC)

    Dr Yoshichika Arakawa

  96. Molecular structure of bacterial endotoxin (Escherichia coli Re lipopolysaccharide): implications for formation of a novel heterogeneous lattice structure

    Article • Molecular Microbiology, May 2000, Wiley

    Dr Yoshichika Arakawa

  97. A preliminary survey of extended-spectrum β-lactamases (ESBLs) in clinical isolates ofKlebsiella pneumoniaeandEscherichia coliin Japan

    Article • FEMS Microbiology Letters, March 2000, Oxford University Press (OUP)

    Dr Yoshichika Arakawa

  98. Role of multiple efflux pumps inEscherichia coliin indole expulsion

    Article • FEMS Microbiology Letters, October 1999, Oxford University Press (OUP)

    Dr Yoshichika Arakawa

  99. Worldwide proliferation of carbapenem-resistant gram-negative bacteria

    Article • The Lancet, September 1999, Elsevier

    Dr Yoshichika Arakawa

  100. Crystallization of Lipopolysaccharide from aSalmonella typhimuriumSemi-Rough (SR) Mutant

    Article • Microbiology and Immunology, August 1999, Wiley

    Dr Yoshichika Arakawa

  101. Induction of Protection against Oral Infection with Cytotoxin–Producing Escherichia coli O157:H7 in Mice by Shiga–like Toxin–Liposome Conjugate

    Article • International Archives of Allergy and Immunology, August 1998, Karger Publishers

    Dr Yoshichika Arakawa

  102. RobA-lnduced Multiple Antibiotic Resistance Largely Depends on the Activation of the AcrAB Efflux

    Article • Microbiology and Immunology, September 1997, Wiley

    Dr Yoshichika Arakawa

  103. Inhibition of the Metallo-.BETA.-lactamase Produced from Serratia marcescens by Thiol Compounds.

    Article • Biological and Pharmaceutical Bulletin, January 1997, Pharmaceutical Society of Japan

    Dr Yoshichika Arakawa

  104. Crystallization of an R-Form Lipopolysaccharide fromKlebsiella pneumoniae

    Article • Microbiology and Immunology, June 1996, Wiley

    Dr Yoshichika Arakawa

  105. Crystallization of SyntheticEscherichia coli-Type Lipid A

    Article • Microbiology and Immunology, January 1996, Wiley

    Dr Yoshichika Arakawa

  106. Crystallization and Analyses of Crystals of Various Chemotypes of R-Form Lipopolysaccharides fromSalmonellaSpp.

    Article • Microbiology and Immunology, August 1994, Wiley

    Dr Yoshichika Arakawa

  107. Lidocaine Hydrochloride and Acetylsalicylate Kill Bacteria by Disrupting the Bacterial Membrane Potential in Different Ways

    Article • Microbiology and Immunology, June 1994, Wiley

    Dr Yoshichika Arakawa

  108. Characterization of a plasmid-borne and constitutively expressed blamox-1 gene encoding AmpC-type β-lactamase

    Article • Gene, February 1994, Elsevier

    Dr Yoshichika Arakawa

  109. Polymorphism of Crystals ofSalmonella minnesotaRe and Ra Lipopolysaccharides

    Article • Microbiology and Immunology, July 1993, Wiley

    Dr Yoshichika Arakawa

  110. Construction of a novel suicide vector: selection for Escherichia coli HB101 recombinants carrying the DNA insert

    Article • Gene, July 1991, Elsevier

    Dr Masanori Watahiki, Dr Yoshichika Arakawa

  111. Electron Microscopic Observation of Crystals ofEscherichia coliK-12 Lipopolysaccharide

    Article • Microbiology and Immunology, August 1990, Wiley

    Dr Yoshichika Arakawa

  112. Rapid Small-Scale Preparation Method of Cell Surface Polysaccharides

    Article • Microbiology and Immunology, July 1990, Wiley

    Dr Yoshichika Arakawa

  113. Inhibitory Effect of Ca2+on Formation of Mg2+-Mediated Two-Dimensional Hexagonal Lattice Structure by an R-Form Lipopolysaccharide fromKlebsiella pneumoniae

    Article • Microbiology and Immunology, May 1990, Wiley

    Dr Yoshichika Arakawa

  114. Relationship between Mg2+-Induced Hexagonal Assembly of R-Form Lipopolysaccharides and Chemical Structure of Their R-Cores

    Article • Microbiology and Immunology, March 1990, Wiley

    Dr Yoshichika Arakawa

  115. Identification of Species and Capsular Types ofKlebsiellaClinical Isolates, with Special Reference toKlebsiella planticola

    Article • Microbiology and Immunology, November 1989, Wiley

    Dr Yoshichika Arakawa

  116. Temperature-Sensitive Growth Mutants as Live Vaccines against Experimental Murine Salmonellosis

    Article • Microbiology and Immunology, December 1987, Wiley

    Dr Yoshichika Arakawa

  117. Close evolutionary relationship between the chromosomally encoded β lactamase gene ofKlebsiellapneumoniaeand the TEM β-lactamase gene mediated by R plasmids

    Article • FEBS Letters, October 1986, Wiley

    Dr Yoshichika Arakawa